Rochira, V. http://orcid.org/0000-0001-8169-0696
Mossetto, G.
Jia, N.
Cannavo, S. http://orcid.org/0000-0001-8779-7283
Beck-Peccoz, P.
Aimaretti, G. http://orcid.org/0000-0002-6186-0106
Ambrosio, M. R. http://orcid.org/0000-0002-7911-9770
Di Somma, C. http://orcid.org/0000-0002-5724-1951
Losa, M.
Ferone, D.
Lubrano, C.
Scaroni, C. http://orcid.org/0000-0001-9396-3815
Giampietro, A. http://orcid.org/0000-0001-5756-2045
Corsello, S. M.
Poggi, M.
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 22 November 2017
Accepted: 1 March 2018
First Online: 13 March 2018
Compliance with ethical standards
:
: Vincenzo Rochira, Salvatore Cannavo, Paolo Beck-Peccoz, Gianluca Aimaretti, Maria R Ambrosio, Carolina Di Somma, Diego Ferone, Carla Lubrano, Carla Scaroni, Antonella Giampietro, Salvatore M. Corsello and Maurizio Poggi declare that they have no conflicts of interest. Gilberto Mossetto and Nan Jia are employees of Eli Lilly and Company. Marco Losa has received consulting fees from Eli Lilly, Ipsen, and Pfizer.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
: The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.